Other Viruses Citation List: February 13 - February 26, 2015

Hepatitis B Virus

1. Validation of Cross-genotype Neutralization by Hepatitis B Virus-specific Monoclonal Antibodies by in Vitro and in Vivo Infection. Hamada-Tsutsumi, S., E. Iio, T. Watanabe, S. Murakami, M. Isogawa, S. Iijima, T. Inoue, K. Matsunami, K. Tajiri, T. Ozawa, H. Kishi, A. Muraguchi, T. Joh, and Y. Tanaka. Plos One, 2015. 10(2): p. e0118062. PMID[25693196].

[PubMed]. OV_0213-022615.

2. Synthesis and anti-Hepatitis B Virus Activity of C4 Amide-substituted Isosteviol Derivatives. Huang, T.J., C.L. Yang, Y.C. Kuo, Y.C. Chang, L.M. Yang, B.H. Chou, and S.J. Lin. Bioorganic & Medicinal Chemistry, 2015. 23(4): p. 720-728. PMID[25600408].

[PubMed]. OV_0213-022615.

Hepatitis C Virus

3. 6-(Azaindol-2-yl)pyridine-3-sulfonamides as Potent and Selective Inhibitors Targeting Hepatitis C Virus NS4B. Chen, G., H. Ren, N. Zhang, W. Lennox, A. Turpoff, S. Paget, C. Li, N. Almstead, F.G. Njoroge, Z. Gu, J. Graci, S.P. Jung, J. Colacino, F. Lahser, X. Zhao, M. Weetall, A. Nomeir, and G.M. Karp. Bioorganic & Medicinal Chemistry Letters, 2015. 25(4): p. 781-786. PMID[25613678].

[PubMed]. OV_0213-022615.

4. Synthesis of 2,3-Dideoxy-2-fluoro-2,3-endo-methylene- and 2,3-Dideoxy-2-fluoro-3-C-hydroxymethyl-2,3-endo-methylene-pentofuranoses and Their Use in the Preparation of Conformationally Locked Bicyclic Nucleosides. Clarkson, R., Z. Komsta, B.A. Mayes, A. Moussa, M. Shelbourne, A. Stewart, A.J. Tyrrell, L.L. Wallis, and A.C. Weymouth-Wilson. Journal of Organic Chemistry, 2015. 80(4): p. 2198-2215. PMID[25615008].

[PubMed]. OV_0213-022615.

5. Supercritical Fluid Extraction of Heather (Calluna vulgaris) and Evaluation of anti-Hepatitis C Virus Activity of the Extracts. Garcia-Risco, M.R., E. Vazquez, J. Sheldon, E. Steinmann, N. Riebesehl, T. Fornari, and G. Reglero. Virus Research, 2015. 198: p. 9-14. PMID[25550074].

[PubMed]. OV_0213-022615.

6. Discovery of Thienoimidazole-based HCV NS5A Inhibitors. Part 1: C2-Symmetric Inhibitors with Diyne and Biphenyl Linkers. Giroux, S., D. Bilimoria, C. Cadilhac, K.M. Cottrell, F. Denis, E. Dietrich, N. Ewing, J.A. Henderson, L. L'Heureux, N. Mani, M. Morris, O. Nicolas, T.J. Reddy, S. Selliah, R.S. Shawgo, J. Xu, N. Chauret, F. Berlioz-Seux, L.C. Chan, S.K. Das, A.L. Grillot, Y.L. Bennani, and J.P. Maxwell. Bioorganic & Medicinal Chemistry Letters, 2015. 25(4): p. 936-939. PMID[25595681].

[PubMed]. OV_0213-022615.

7. Discovery of Thienoimidazole-based HCV NS5A Inhibitors. Part 2: Non-Symmetric Inhibitors with Potent Activity against Genotype 1a and 1b. Giroux, S., D. Bilimoria, C. Cadilhac, K.M. Cottrell, F. Denis, E. Dietrich, N. Ewing, J.A. Henderson, L. L'Heureux, N. Mani, M. Morris, O. Nicolas, T.J. Reddy, S. Selliah, R.S. Shawgo, J. Xu, N. Chauret, F. Berlioz-Seux, L.C. Chan, S.K. Das, A.L. Grillot, Y.L. Bennani, and J.P. Maxwell. Bioorganic & Medicinal Chemistry Letters, 2015. 25(4): p. 940-943. PMID[25597006].

[PubMed]. OV_0213-022615.

8. Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection. Hansson, M.J., S.J. Moss, M. Bobardt, U. Chatterji, N. Coates, J.A. Garcia-Rivera, E. Elmer, S. Kendrew, P. Leyssen, J. Neyts, E.A.M. Nur, T. Warneck, B. Wilkinson, P. Gallay, and M.A. Gregory. Chemistry & Biology, 2015. 22(2): p. 285-292. PMID[25619934].

[PubMed]. OV_0213-022615.

9. Synthesis and Evaluation of NS5A Inhibitors Containing Diverse Heteroaromatic Cores. Henderson, J.A., D. Bilimoria, M. Bubenik, C. Cadilhac, K.M. Cottrell, F. Denis, E. Dietrich, N. Ewing, G. Falardeau, S. Giroux, L. L'Heureux, B. Liu, N. Mani, M. Morris, O. Nicolas, O.Z. Pereira, C. Poisson, T.J. Reddy, S. Selliah, R.S. Shawgo, L. Vaillancourt, J. Wang, J. Xu, N. Chauret, F. Berlioz-Seux, L.C. Chan, S.K. Das, A.L. Grillot, Y.L. Bennani, and J.P. Maxwell. Bioorganic & Medicinal Chemistry Letters, 2015. 25(4): p. 948-951. PMID[25577039].

[PubMed]. OV_0213-022615.

10. Benzimidazole-containing HCV NS5A Inhibitors: Effect of 4-Substituted Pyrrolidines in Balancing Genotype 1a and 1b Potency. Henderson, J.A., D. Bilimoria, M. Bubenik, C. Cadilhac, K.M. Cottrell, E. Dietrich, F. Denis, N. Ewing, G. Falardeau, S. Giroux, R. Grey, Jr., L. L'Heureux, B. Liu, N. Mani, M. Morris, O. Nicolas, O.Z. Pereira, C. Poisson, B. Govinda Rao, T.J. Reddy, S. Selliah, R.S. Shawgo, L. Vaillancourt, J. Wang, C.G. Yannopoulos, N. Chauret, F. Berlioz-Seux, L.C. Chan, S.K. Das, A.L. Grillot, Y.L. Bennani, and J.P. Maxwell. Bioorganic & Medicinal Chemistry Letters, 2015. 25(4): p. 944-947. PMID[25577041].

[PubMed]. OV_0213-022615.

11. Enantioselective Synthesis, Stereochemical Correction, and Biological Investigation of the Rodgersinine Family of 1,4-Benzodioxane Neolignans. Pilkington, L.I., J. Wagoner, S.J. Polyak, and D. Barker. Organic Letters, 2015. 17(4): p. 1046-1049. PMID[25671292].

[PubMed]. OV_0213-02261.

12. Targeting Cellular Squalene Synthase, an Enzyme Essential for Cholesterol Biosynthesis, Is a Potential Antiviral Strategy against Hepatitis C Virus. Saito, K., Y. Shirasago, T. Suzuki, H. Aizaki, K. Hanada, T. Wakita, M. Nishijima, and M. Fukasawa. Journal of Virology, 2015. 89(4): p. 2220-2232. PMID[25473062].

[PubMed]. OV_0213-022615.

13. Prodrugs of Imidazotriazine and Pyrrolotriazine C-Nucleosides Can Increase anti-HCV Activity and Enhance Nucleotide Triphosphate Concentrations in Vitro. Tyndall, E.M., A.G. Draffan, B. Frey, B. Pool, R. Halim, S. Jahangiri, S. Bond, V. Wirth, A. Luttick, D. Tilmanis, J. Thomas, K. Porter, and S.P. Tucker. Bioorganic & Medicinal Chemistry Letters, 2015. 25(4): p. 869-873. PMID[25592710].

[PubMed]. OV_0213-022615.

Herpes Simplex Virus 2

14. Characterization and Biological Effects of Two Polysaccharides Isolated from Acanthopanax sciadophylloides. Lee, J.B., T. Tanikawa, K. Hayashi, M. Asagi, Y. Kasahara, and T. Hayashi. Carbohydrate Polymers, 2015. 116: p. 159-166. PMID[25458285].

[PubMed]. OV_0213-022615.

Citations from the ISI Web of Knowledge Listings for O.V.

15. Antiviral Drug Discovery: Broad-spectrum Drugs from Nature. Martinez, J.P., F. Sasse, M. Bronstrup, J. Diez, and A. Meyerhans. Natural Product Reports, 2015. 32(1): p. 29-48. ISI[000348486000002].

[WOS]. OV_0213-022615.

16. Novel 4-Thiazolidinones as Non-nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-dependent RNA Polymerase. Cakir, G., I. Kucukguzel, R. Guhamazumder, E. Tatar, D. Manvar, A. Basu, B.A. Patel, J. Zia, T.T. Talele, and N. Kaushik-Basu. Archiv der Pharmazie, 2015. 348(1): p. 10-22. ISI[000347710600003].

[WOS]. OV_0213-022615.

17. Benzhydrylpiperazine Compounds Inhibit Cholesterol-dependent HCV Entry. Chamoun-Emanuelli, A.M. and Z.L. Chen. Abstracts of Papers of the American Chemical Society, 2014. 247: Poster #22. ISI[000348455200351].

[WOS]. OV_0213-022615.